Drug giant pulls weight loss pill as obese patients suffer string of horrible side effects

Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news